NUTRAINGREDIENTS AWARDS 2018: Meet the winners

In it to win it: INFAT win ingredients award in infant nutrition category

By Will Chu

- Last updated on GMT

Winners of this year’s NutraIngredients Award for Infant Nutrition Ingredient of the Year, Advanced Lipid's INFAT.
Winners of this year’s NutraIngredients Award for Infant Nutrition Ingredient of the Year, Advanced Lipid's INFAT.
For Advanced Lipids, winners of this year’s NutraIngredients Award for Infant Nutrition Ingredient of the Year, the award very nearly didn’t happen.
Ewa Hudson Infat tweet

The Swedish-based firm scooped top honours last week for their product INFAT, a structured vegetable oil containing SN-2 palmitate, or OPO, which mimics the structure of human milk fat.

“When it comes to innovation, we were asking what it meant,”​ explained Dr Marcus Gliwitzki, chairman of Advanced Lipids.

“SN-2 palmitate, which is the chemical name for our ingredient, is not a novel ingredient in the market as it was introduced in the 90s.

“We thought we did a good job of developing the market specifically in China as well as introducing the concept and scientific evidence to the customer and make it more of a tangible benefit for the consumer.

“We believe this made the difference and gave us a fair chance of winning the award.”

Pooling of expertise

Infat tweet

INFAT is the result of a joint venture established by biotech company Enzymotec, a member of the Frutarom group and AAK, a producer and supplier of vegetable fats and oils for the infant formula industry.

It was this combination of clinical and chemical expertise in lipid technologies that stood out for the judging panel, who noted the research pointing to the ingredient’s benefits for infant development.

“INFAT benefits from being much closer structurally to human milk resulting in a stool consistency that is much softer, higher absorption of calcium and fatty acid,”​ said Dr Glitwitzki.

“We see a greater mineral and bone density in infants when compared to infants that receive a formula with normal vegetable oil.

Dr Glitwitzki also points to a bifidogenic effect observed with the ingredient pointing to a higher lactobacillus ​count in infants receiving a formula containing INFAT

It is during the first 2 years of life that the gut flora is most active in its development and colonization of the gut, playing a large role in the health of the baby later in life.

A recent double blind controlled study​ showed that feeding with INFAT containing formula for the first 6 weeks of life not only increased lactobacillus​ count but also bifidobacteria​ numbers in faecal stools compared to a control formula.

Mother’s milk the standard

Winners at NI Awards

Speaking about the product’s recognition at the awards ceremony in Geneva, Ronald van der Knaap, CEO of Advanced Lipids, said, “It’s an honour to have received this prestigious award and we’re absolutely delighted.”

“Mother’s milk will always be the gold standard of infant nutrition, but OPO ingredients like Infat help formula manufacturers come as close to mother's milk as possible.

“Both Frutarom and AAK are extremely proud of the expert team at Advanced Lipids who have contributed so much to scientific and consumer awareness of the benefits of OPO for infants and their parents.”

“We got a lot of response after winning the award,”​ added Dr Glitwitzki.

“In a market like China, if you win a European award, it says a lot about the product. So we’re very confident that we can leverage the success of this award. It is very important to us and were very proud.”

 

Related news

Related products

show more

Actilight® and infant nutrition: new perspectives

Actilight® and infant nutrition: new perspectives

Tereos | 31-Aug-2021 | Technical / White Paper

Addition of prebiotic ingredients to formulas started around 30 years ago and is widely recognized by experts. Actilight® scFOS is safe for use in infant...

Business case: private label iron supplements

Business case: private label iron supplements

PharmaLinea Ltd. | 18-May-2021 | Case Study

A line of clinically supported private label iron supplements by PharmaLinea is selling nearly 500.000 units/year in a market of under 20 million people.

Time to rethink your probiotics for infant use

Time to rethink your probiotics for infant use

Morinaga Milk Industry Co., Ltd. | 17-Sep-2020 | Technical / White Paper

Undoubtedly, probiotics-fortified infant nutrition products have hit the mainstream, and a baby-friendly concept is on the consumer radar. Morinaga's...

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Related suppliers

Follow us

Products

View more

Webinars